Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.
AUTOR(ES)
White, D J
RESUMO
CASE REPORT--SUBJECTS--Three cases are described of long-standing vaginal candidosis due to Candida glabrata. These had failed to respond to local and systemic antifungals. In each case the infecting strain appeared resistant to a range of azole drugs in vitro. CLINICAL COURSE--Case one--This patient recovered following prolonged treatment with oral itraconazole in combination with oral and vaginal nystatin. Case two. Yeasts were eradicated from this patient following cyclical treatment with oral dydrogesterone; prolonged vaginal treatment with nystatin may have helped. Case three. This patient did not respond to a prolonged course of oral itraconazole in combination with vaginal and oral nystatin, oral medroxyprogesterone or intravaginal boric acid. Eradication of C glabrata was finally achieved by local application of 1% gentian violet. Shortly after eradication of the C glabrata infection, both Case two and Case three developed infections with other Candida species responsive to azole antifungals.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1195041Documentos Relacionados
- Characterization of an azole-resistant Candida glabrata isolate.
- Molecular biological characterization of an azole-resistant Candida glabrata isolate.
- Enhanced oxidative killing of azole-resistant Candida glabrata strains with ERG11 deletion.
- Restriction fragment length polymorphism analysis of azole-resistant and azole-susceptible Candida albicans strains.
- Formation of Azole-Resistant Candida albicans by Mutation of Sterol 14-Demethylase P450